Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles.

scientific article published on 26 June 2017

Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/ICB.2017.53
P698PubMed publication ID28649995

P50authorMichael MaesQ30504745
P2093author name stringEdna Maria Vissoci Reiche
Andréa Name Colado Simão
Isaias Dichi
Marcell Alysson Batisti Lozovoy
Bruna Miglioranza Scavuzzi
Neide Tomimura Costa
Nicole Perugini Stadtlober
Tatiana Mayumi Veiga Iriyoda
Lorena Flor da Rosa Franchi Santos
Poliana Macedo Guimarães
P2860cites workThe role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunityQ24805385
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathwaysQ26823313
Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus ErythematosusQ58192318
Relationship of total and abdominal adiposity with CRP and IL-6 in womenQ61565678
Serum cytokine profile in patients with active lupus nephritisQ63431624
Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese HumansQ63866263
Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjectsQ64386571
The polymorphisms of HLA-DR and TNF B loci in northern Chinese Han nationality and susceptibility to systemic lupus erythematosusQ64389217
Serum levels of interferons in patients with systemic lupus erythematosusQ69018287
Vitamin D3 metabolism in patients with rheumatic diseases: Low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosusQ71809479
Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with systemic lupus erythematosusQ72861351
Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)Q73310096
Relation of a TNF gene polymorphism to severe sepsis in trauma patientsQ78138519
Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndromeQ84830607
Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosusQ84948994
Relationship between vitamin D, IFN-γ, and E2 levels in systemic lupus erythematosusQ86259027
Oxidative Stress and Treg and Th17 Dysfunction in Systemic Lupus ErythematosusQ28071300
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosusQ29614922
Nonclassic actions of vitamin DQ33375907
The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosusQ33532591
Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosusQ33923351
Tumor necrosis factor gene polymorphisms, leukocyte function, and sepsis susceptibility in blunt trauma patientsQ34174880
Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypesQ34360668
25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohortQ35086343
Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosusQ35146576
Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemiaQ35555688
TNFB gene polymorphism in patients with systemic lupus erythematosus in KoreanQ35938903
The Role of IL-17 and Th17 Lymphocytes in Autoimmune DiseasesQ36249305
Increased activation of toll-like receptors-7 and -8 of peripheral blood mononuclear cells and upregulated serum cytokines in patients with pediatric systemic lupus erythematosusQ36492750
Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementationQ36633225
Cytokines in systemic lupus erythematosusQ36659210
1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cellsQ36993676
Clinical associations of IL-10 and IL-37 in systemic lupus erythematosusQ37314750
Serum Cytokines Th1, Th2, and Th17 Expression Profiling in Active Lupus Nephritis-IV: From a Southern Chinese Han PopulationQ37322751
C-reactive protein and systemic lupus erythematosusQ37335303
Roles of interferon-gamma and interleukin-4 in murine lupusQ37365961
Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon alphaQ37690988
Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advancesQ37751877
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practiceQ37769948
Th subset balance in lupus nephritisQ37929551
Vitamin D and systemic lupus erythematosus: continued evolutionQ38293366
Eppur Si Muove: vitamin D is essential in preventing and modulating SLE.Q38711934
Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodiesQ38806513
Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activityQ41486353
1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.Q43775059
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.Q44441787
Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systemic lupus erythematosusQ44854237
Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosusQ45058181
The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trialQ45765902
Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.Q46503835
Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosusQ47221390
P433issue9
P921main subjectsystemic lupus erythematosusQ1485
P304page(s)824-831
P577publication date2017-06-26
P1433published inImmunology & Cell BiologyQ13731918
P1476titleCytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles
P478volume95

Reverse relations

cites work (P2860)
Q60957010ATF4 Involvement in TLR4 and LOX-1-Induced Host Inflammatory Response to Keratitis
Q91964435B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments
Q87998045Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus
Q90459883Comparing the Protection Imparted by Different Fraction Extracts of Garlic (Allium sativum L.) against Der p-Induced Allergic Airway Inflammation in Mice
Q52648672Effects of various radiation doses on induced T-helper cell differentiation and related cytokine secretion.
Q57469182Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
Q99583494Expressions of IFN-γ and IL-4 before and after Treatment of Lupus Nephritis with Traditional Chinese Medicine Combined with Cyclophosphamide and Their Values for Efficacy Prediction and Evaluation
Q99565399Facial erythema after the treatment of dupilumab in SLE patient
Q56767031Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses
Q90469371IL-17 is Aberrantly Overexpressed Among Under-treatment Systemic Lupus Erythematosus Patients
Q46252278Increased lipid and protein oxidation and lowered anti-oxidant defenses in systemic lupus erythematosus are associated with severity of illness, autoimmunity, increased adhesion molecules, and Th1 and Th17 immune shift.
Q55260371MicroRNA-326 Upregulates B Cell Activity and Autoantibody Production in Lupus Disease of MRL/lpr Mice.
Q92759525Molecular pathobiology of scleritis and its therapeutic implications
Q55266542Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus.
Q63433111Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases
Q93157162Relationship between Neutrophil-to-Lymphocyte Ratio and Systemic Lupus Erythematosus: A Meta-analysis
Q64240256Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
Q99711563T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells
Q56767037The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder
Q91423531The IL-12-STAT4 axis in the pathogenesis of human systemic lupus erythematosus
Q93219852Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes

Search more.